Canadian Organization for Rare Disorders
Canadian Organization for Rare Disorders has met with MPs 5 times since January 2024, reaching 5 MPs across 3 parties. Most recent contact: July 30, 2026.
What they're asking for
In the registry's own words. Descriptions are only filed for meetings since mid-2024.
Enhancement to Canada's regulatory and funding environment for new rare disease medicines, including Health Canada authorizations of medicines and framework for clinical trials, health technology assessment processes, reimbursement negotiations and funding decisions to improve access for rare disease patients
July 30, 2026 · Raquel Dancho · Conservative · Health; Industry; Intellectual Property; Science and Technology; Budget
Enhancement to Canada's regulatory and funding environment for new rare disease medicines, including Health Canada authorizations of medicines and framework for clinical trials, health technology assessment processes, reimbursement negotiations and funding decisions to improve access for rare disease patients.
May 26, 2026 · Helena Jaczek · Liberal · Health; Industry; Intellectual Property; Science and Technology; Budget
Establish Innovation, Science and Economic Development Canada policies related to research and development of treatments for rare disorders
October 10, 2025 · Luc Thériault · Bloc Québécois · Health; Industry; Science and Technology; Budget; Research and Development
Full meeting log
5 MP-directed communications since January 2024, from the Registry of Lobbyists.
| Date | MP |
|---|---|
| 2026-07-30 | Raquel Dancho · Conservative |
| 2026-06-04 | Tom Kmiec · Conservative |
| 2026-05-26 | Helena Jaczek · Liberal |
| 2026-05-26 | Marcus Powlowski · Liberal |
| 2025-10-10 | Luc Thériault · Bloc Québécois |